Health TrialsbyHealthPanel

Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction

ConditionHeart Failure With Preserved Ejection Fraction (HFPEF)
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity of Florida

About this trial

Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

HFpEF

Disqualifiers

Renal insufficiency

Trial design

Design model

Single group

Treatments tested in this trial

  • Ferumoxytol infusion

    Drug

    Ferumoxytol infusion followed by cardiac MRI

Treatment groups

70 Participants
are divided into 1 treatment group
Group A: Single arm study of subjects with HFpEFExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

detection of inflammation

Time frame
72 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Florida

Lead sponsor

American Heart Association

Collaborator

Source ClinicalTrials.gov
Apply now